← back to search

Han Yang

Shenyang Pharmaceutical University · CN
Area of research
Radiation · Hepatology
Research interest
Research interests include Advanced Radiotherapy Techniques, Hepatocellular Carcinoma Treatment and Prognosis, Immunotherapy and Immune Responses, and CAR-T cell therapy research.
h-index
16
citations
902
works
47
NIH funding
primary concept
email

Recent publications

Combined BNCT-CIRT treatment planning for glioblastoma using the effect-based optimization
Physics in Medicine and Biology 2023cited by 4position: firstdoi
Defined tumor antigen-specific T cells potentiate personalized TCR-T cell therapy and prediction of immunotherapy response
Cell Research 2022cited by 172position: middledoi
CAR-T cells targeting CLL-1 as an approach to treat acute myeloid leukemia
Journal of Hematology & Oncology 2018cited by 196position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Penghui Zhou · Huaiyin Institute of Technology2 papers (2018–2022)Xiaojun Xia · Zhejiang International Studies University2 papers (2018–2022)Wende Li · Sun Yat-sen University Cancer Center2 papers (2018–2022)Shuangye Liao · Sun Yat-sen University2 papers (2018–2022)Tiebang Kang · Sun Yat-sen University2 papers (2018–2022)Siyu Chen · Shanghai Medical College of Fudan University2 papers (2018–2022)Wei Xiao · Sun Yat-sen University1 papers (2018–2018)Kuai Yu · Shenzhen University1 papers (2022–2022)Xiaobin Tang · Chongqing University1 papers (2023–2023)Kaiyu Zhu · Central South University1 papers (2022–2022) · 1 papers (2022–2022)Shuo Yang · China University of Geosciences (Beijing)1 papers (2018–2018)Xiuyu Cai · Hebei University of Engineering1 papers (2018–2018)Xinxin Xiong · Northeast Normal University1 papers (2022–2022)Wenjian Liu · Qingdao University1 papers (2018–2018)Nawei Liu · Regenex Pharmaceuticals (China)1 papers (2018–2018)Peirong Ding · Wuhan Union Hospital1 papers (2022–2022) · 1 papers (2023–2023)Liping Xu · Wayne State University1 papers (2018–2018)Jianeng Zhang · Sun Yat-sen University1 papers (2018–2018)